Showing posts with label Conditions and Diseases. Show all posts
Showing posts with label Conditions and Diseases. Show all posts

Friday, October 14, 2011

Taking The Myths Out Of Pudendal Nerve Entrapment Surgery

Imagine someone with chronic pelvic pain or genital pain so severe that sitting, having sex, or holding a job becomes impossible. Unable to maintain normal relationships, this person may lose hope and fall into despair because no one understands. Finally, the patient is given a diagnosis of pudendal neuralgia due to possible pudendal nerve entrapment (PNE) that may require surgery; but for patients with PNE, making a decision about pudendal nerve decompression surgery can be very confusing. While some physicians recognize the value of PNE surgery, it is not unusual for patients with PNE to be told that surgery will not help them and that they will have to learn to live with severe pelvic pain for the rest of their lives. Many patients who are considering PNE surgery have exhausted conservative treatments such as physical therapy, medications, or nerve blocks, and are still living in serious debilitating pain. Hearing conflicting opinions from health care providers may leave a patient who has chronic genital pain wondering where to turn. More educational information is needed to dispel some of the myths related to surgical treatment of PNE.
Myth # 1

Surgery should not be considered an option for people with PNE because it is too risky and its efficacy has not been established.

There continues to be disagreement in the medical world as to whether surgery should be an option for patients with pudendal neuralgia. In some instances patients are worse after surgery, and in approximately one-third of patients, there is no improvement.(2) Naturally, these patients continue to seek medical treatment after surgery which may cause some health care providers to question the efficacy of PNE surgery. Some post-operative patients who have had ligaments cut during surgery have reported developing sacroiliac joint dysfunction, piriformis syndrome, levator ani muscle spasm, and coccyx pain after pudendal nerve surgery. Other patients have reported new problems such as penile/clitoral numbness or pain in areas they did not experience before.
Despite the risks, according to publications in peer reviewed literature and anecdotal evidence from numerous patients, surgery can often bring significant relief in a patient's pain levels, and many patients experience dramatic improvements that allow them to resume a normal life. The challenge for the diagnostician is to determine which patients are most likely to have a positive outcome, but to date (September 2011), there is no test proven to offer 100% accuracy.(3) History and physical examination remain important in the diagnosis. Traditionally, pudendal nerve blocks have been used as a tool to diagnose a possible entrapment,(4) but there are occasional reports of patients who have become permanently worse from pudendal nerve blocks. While still used by some physicians, the value of a pudendal nerve motor latency test (PNMLT) in the diagnosis of pudendal neuropathy has not been established.(5) Recently, a special type of 3 Tesla Magnetic Resonance Imaging (MRI) has shown some promise in locating specific sites of entrapment. When a patient is deemed to be a possible surgery candidate based on the clinical exam, history, PNMLT, 3 Tesla MRI, and response to nerve blocks, the patient, in consultation with physicians, then faces the decision of which type of PNE surgery to choose.
Ads by Google
- Umfassende Branchenkompetenz im Gesundheitswesen. Fragen Sie uns! -
- controlled rate freezing for stem cells, mouse transgenics & IVF - - Translational preclinical contract research services. -
Myth #2

There is a "best" approach or protocol for pudendal nerve decompression surgery.


The pudendal nerve lies deep in the pelvis, and accessing all sites of possible entrapment presents a challenge to the surgeon. There are five basic approaches to pudendal nerve decompression surgery, but there is no consensus in the medical community as to which approach is best because there are several possible sites of entrapment. The transgluteal approach is the most widely used approach to pudendal nerve decompression because it offers the surgeon the best visualization of the nerve at the most common sites of entrapment.

1. Perineal Approach

The first pudendal nerve decompression surgeries were recorded by Shafik in 1994(6) and were performed for the treatment of erectile dysfunction (ED) using a transperineal approach in which a para-anal incision was made and the inferior rectal branch of the pudendal nerve was followed to the pudendal (Alcock's) canal. A slit was made in the canal to release the pudendal nerve, and six of the seven patients had a subsequent improvement in erectile dysfunction. In a later publication,(7) Shafik reported success in the treatment of vulvodynia, using a similar surgical approach.

Since then, Beco(8) and de Bisschop(9) have published results of perineal surgery, and both have reported that a majority of patients have significant improvement in pain levels. With the perineal approach, a small incision is made in the perineum, and part of the nerve can be accessed without ligaments being severed, although access to the ligaments at the ischial spine, a common site of entrapment, is limited and requires a rectoscope.

2. Trans-Gluteal (TG) Approach

In 1998 Robert, et al(10) published on results of 150 transgluteal surgeries in which the pudendal nerve is accessed via an incision in the gluteal muscle and the sacrotuberous ligament. He reports that 45% were cured and an additional 22% improved. Robert describes several sites of entrapment along the course of the pudendal nerve including at the "ligamentous pinch" between the sacrotuberous and sacrospinous ligaments, at the piriformis muscle, the falciform process of the sacrotuberous ligament, or in the fascia of the obturator internus muscle at the Alcock's canal.

Robert's team published the results of a randomized controlled trial in 2005,(11) reporting that after one year, 70% of the surgical group were improved versus 13% of the non-surgical group.

Popeney, et al(12) published results of 58 cases of PNE surgery in 2008, reporting that in using the transgluteal approach as described by Robert, 60% of patients had greater than 50% improvement.

Based on Vleeming's research demonstrating the importance of the sacrotuberous (ST) ligament in stabilizing the sacroiliac joint,(13) some physicians who wish to preserve the integrity of the ST ligament to prevent possible post-operative pelvic instability offer a modified TG approach that spares the ST ligament or replaces it with cadaver tendon as described by Hibner.(14) Some surgeons make a vertical instead of a horizontal cut in the ligament and suture the ligament after the nerve is decompressed.

3. The Trans-Ischio-Rectal-Fossa (TIR) Approach

In the TIR approach as described by Bautrant in 2003,(15) a small (5 cm) incision is made in the posterior wall of the vagina in women or between the anus and scrotum in men. The sacrospinous ligament is accessed by dissection of the ischio-rectal trench and pushing aside the rectum. In most cases the sacrospinous ligament is sectioned to release the nerve between the ligaments at the ischial spine. With this approach, access to the sacrotuberous ligament is limited, requiring an endoscope. Bautrant reported that at 6 months, 66% were asymptomatic or satisfied with their improvement, and at one year this number increased to 86%.

4. The Laparoscopic Trans-Peritoneal Approach

Possover published results of using a laparoscopic approach for Alcock's canal decompression surgery and reports success in 15 out of 18 patients.(16) Using the laparoscopic approach as described by Possover allows neurolysis of the sacral plexus, focusing primarily on the proximal and medial portions of the pudendal nerve.

5. The Dorsal Nerve Approach

In 2005 Hubry, et al(17) described a possible site of entrapment distal to the urogenital diaphragm at the dorsal branch of the pudendal nerve. Recently, several surgeons have begun performing nerve release surgery on the dorsal nerve of the penis and clitoris, but as of September 2011, no results have been published on this approach.

Myth #3

PNE decompression surgery is like any other surgery. If you have not improved soon after surgery, the procedure should be considered a failure.


Unfortunately, it can take many months for nerves to heal, and autonomic, motor, and sensory function may never be complete.(18) During the recovery period, patients may require significant amounts of pain relief medication for an extended period of time while healing takes place. For unsuccessful surgeries, patients will require pain control for indefinite periods of time.

Considerations before Choosing PNE Surgery

It is easy to see why patients with pudendal neuralgia agonize over the decision as to whether to opt for pudendal nerve decompression surgery and which surgery approach to choose. Having spoken with hundreds of pudendal neuralgia patients, I believe there are two key considerations that must be remembered when deciding on PNE surgery.

1. Has the patient tried conservative therapies first (unsuccessfully), and has his or her illness taken away abilities to function, to enjoy life, and to have normal relationships?

2. Is the patient fully informed as to the advantages and disadvantages of each surgical approach, of the risks involved, and thereby mentally prepared for the possibility of an unsuccessful outcome?

Patients undergoing PNE surgery desperately need the non-critical support of family, friends, and health care providers. If the procedure is not successful, they don't need to hear "you should not have done that." They just need someone to give them hope and help them in their search for a way to silence the pain.

Written by: Violet Matthews, RN, BSN, Secretary, Health Organization for Pudendal Education

Tuesday, September 27, 2011

Exercise and Your Heart: A Little Bit'll Do It



It doesn't take much exercise to help reduce your risk of heart disease. A new review of 33 earlier studies on the benefits of exercise found that people who get 150 minutes of moderate exercise per week reduce their risk of heart disease by 14 percent compared to inactive people (150 minutes comes out to 30 minutes a day, five days a week). Of course, more is better, and with additional physical activity (five hours of exercise per week) you can lower your risk by as much 20 percent (again, compared to inactive folks). The review found that women benefit more from exercise than men, but the researchers aren't sure why and have suggested that the difference may be due to a statistical quirk. You might also achieve an additional risk reduction of five percent if you're up for exercising 12.5 hours per week, but the researchers conceded that the extra five percent may not be worth all that added effort. The study was published online August 1 in Circulation.

Friday, September 16, 2011

Potential New Hope And Treatment For Endometrial Cancer Released







Advanced endometrial cancer refers to several types of malignancies that arise from the endometrium, or lining, of the uterus. Endometrial cancers are the most common gynecologic cancers in the United States, with over 35,000 women diagnosed each year. However, in a new research, there may be progress to a single treatment solution called AEZS-108.

Overall, "tolerability" of AEZS-108 was good and commonly allowed retreatment as scheduled. Only one patient had a dose reduction, and less than 10% of treatment courses were postponed, including more than half of the cases in which the delay was not related to toxicity.

Good tolerability of AEZS-108 was also reflected by a low rate of severe non-hematological possibly drug-related adverse events which included single cases each of nausea, diarrhea, fatigue, general health deterioration, creatinine elevation, and blood potassium decrease. No cardiac toxicity was reported.

Juergen Engel, Ph.D., President and CEO of Aeterna Zentaris comments:

"We would first like to thank Dr. Wimberger and all those involved in this trial for their dedicated work which is now being presented to the international gynecological community. We are very excited about these final results achieved with AEZS-108 alone, which compare favorably with those usually seen with more aggressive and less well tolerated combination regimens for endometrial cancer. On this basis, we have requested Parallel Scientific Advice from both the FDA and the EMA for the further pivotal development of AEZS-108 in this indication in the upcoming months."


The referred to Dr. Wimberger added:

"The safety and efficacy of AEZS-108 in our study on advanced endometrial cancer was very encouraging. Although used as a single agent treatment only, AEZS-108 achieved good response rates and disease stabilization. Personally, I was impressed to see three responses in the five patients treated at my institution, including one long-lasting complete response."


This year, the American Cancer Society estimates that more than 43,000 cases of endometrial cancer will be diagnosed in the United States. Symptoms can include unexplained vaginal bleeding, painful urination, painful intercourse and soreness in the pelvic area. There is no routine test to identify endometrial cancer.

Endometrial cancer may sometimes be referred to as uterine cancer. However, different cancers may develop not only from the endometrium itself but also from other tissues of the uterus, including cervical cancer, sarcoma of the myometrium, and trophoblastic disease.

Treatment options include surgery, radiation therapy, hormone therapy and chemotherapy; however, there are new treatments in development that work by targeting and destroying cancerous cells.

Basically, AEZS-108 represents a new targeting concept in oncology using a hybrid molecule composed of a synthetic peptide carrier and a well-known chemotherapy agent, doxorubicin. AEZS-108 is the first intravenous drug in a clinical study that directs the chemotherapy agent specifically to LHRH-receptor expressing tumors, resulting in more targeted treatment with less damage to healthy tissue.

Currently, the primary treatment is surgical. Surgical treatment should consist of, at least, cytologic sampling of the peritoneal fluid, abdominal exploration, palpation and biopsy of suspicious lymph nodes, abdominal hysterectomy, and removal of both ovaries (bilateral salpingo-oophorectomy).

Lymphadenectomy, or removal of pelvic and para-aortic lymph nodes, is sometimes performed for tumors that have high risk features, such as pathologic grade 3 serous or clear-cell tumors, invasion of more than 1/2 the myometrium, or extension to the cervix or adnexa. Sometimes, removal of the omentum is also performed.


Enhanced by Zemanta

Chronic Vulvar Pain A Reality For More Than 100,000 Women In Southeast Michigan

Illustration of the pain pathway in René Desca...Image via Wikipedia

For more than 100,000 area women, chronic vulvar pain (pain at the opening to the vagina) is so severe it makes intercourse, and sometimes sitting for long periods of time, painful, if not impossible.

A new study from the University of Michigan, which surveyed 2,269 women in the metro Detroit area, found that more than 25 percent of women have experienced ongoing vulvar pain at some point in their lives. However, only two percent of women sought treatment for their pain.

For some, vulvar pain may be caused by activities like biking, tampon use, or intercourse, and for others it can be a persisting, spontaneous pain that can persist for up to 40 years.

Vulvodynia is characterized by a burning, irritation, or sharp pain near the opening of the vagina. The location, constancy and severity of the pain vary among women. Some women say they feel a slight discomfort, while others claim to suffer from knife-like pain. Common treatments, including topical creams, are typically directed towards alleviating symptoms and usually only provide partial pain relief.
The study, available online ahead of print in the American Journal of Obstetrics and Gynecology, found that aside from the 9.2 percent of women who reported that they were currently experiencing pain consistent with vulvodynia, an additional 17.9 percent of women reported they have experienced symptoms of vulvodynia in the past.

That factors to over 318,000 women in southeast Michigan alone.

"What this means for area women is that vulvar pain is common, it has a name, and it can be addressed with their physicians," says Barbara D. Reed, M.D., M.S.P.H, a professor of family medicine at the U-M Medical School and lead author of the study.

What researchers have found concerning is that of the two percent of women who sought treatment for their pain, five percent received a diagnosis of vulvodynia. Many women were misdiagnosed with either yeast infections or estrogen deficiency and the subsequent treatment plans they were recommended did little to alleviate their pain, suggesting these may not be causing their symptoms.

The primary goal of the study was to gain insight on the demographics of women with vulvar pain suggesting vulvodynia. Based on survey responses, researchers were able to determine the ethnicities and ages of those women with vulvar discomfort, as well as the intensity of the pain they experienced.

"With this knowledge, we better understand how common this disorder is, and who is likely to be affected. Knowing this should make it easier for medical providers to expect to see women with this problem, and will therefore make the diagnosis earlier so that treatment can proceed," Reed says.
Article adapted by Medical News Today from original press release. Visit our  pain / anesthetics section for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:

Enhanced by Zemanta
 
Design by Free WordPress Themes | Bloggerized by Lasantha -